A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

Summary

Study researchers think that a drug called enasidenib may help people with clonal cytopenia of undetermined significance (CCUS) because the drug blocks the mutated IDH2 protein, which may improve blood cell counts. The purpose of this study is to find out whether enasidenib is a safe and effective treatment for CCUS.

Timeline

Start

2021-10-06

Primary completion

2026-01-26

Completion

2026-01-26

Drugs

Indications